
Gelenis Domingo
Hematologist and Oncologist · Memorial Cancer Institute
Credentials: · · · · · ·
History
- Present
Memorial Cancer Institute
- 2013–2016
- 2008–2009
Research
Review · International Journal of Molecular Sciences · 2024 · 26 citations
EGF receptor in lung cancer: a successful story of targeted therapy
Review · Expert Review of Anticancer Therapy · 2010 · First of 6 authors · 11 citations
Clinical consequences of resistance to ALK inhibitors in non-small cell lung cancer
Review · Expert Review of Respiratory Medicine · 2020 · Last of 3 authors · 9 citations

4 papers

2 papers

2 papers
- AY
1 paper
- AP
1 paper

1 paper · 1 as a fellow
- DO
1 paper

1 paper
Clinical trials
- 2023–2028
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
- 2019–2029
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 2, Phase 3
SWOG Cancer Research Network


